Results 211 to 220 of about 22,949 (256)

Correction: Venetoclax treatment for chronic lymphocytic leukemia/small lymphocytic leukemia in Japan: post-marketing surveillance. [PDF]

Int J Hematol
Ito T, Kamimura T, Kiguchi T, Kato K, Takenaka R, Kobayashi M, Ito A, Sakai M, Izutsu K.   +8 more
europepmc   +1 more source

Correction to "Safety and Effectiveness of Ixekizumab in Japanese Patients with Psoriasis Vulgaris, Psoriatic Arthritis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis: Post-marketing Surveillance". [PDF]

J Dermatol
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Post-marketing surveillance of sertindole

International Journal of Psychiatry in Clinical Practice, 2002
The atypical antipsychotic drug, sertindole, like several other drugs, causes QT interval prolongation. Prolongation of the QT interval on the electrocardiogram has been associated with an increased risk of ventricular arrhythmia, including the more serious form, torsades de pointes, and is thus a safety concern for the authorities.
exaly   +3 more sources

Clinical trials in post-marketing surveillance of drugs

Contemporary Clinical Trials, 1982
Abstract Based on a literature review, the value of clinical trials as a method for satisfying the objectives of a post-marketing drug surveillance (PMS) system is discussed. Although clinical trials serve an important role in this system, it is shown that other methods must also be incorporated to meet all of the objectives of PMS.
E O'Brian Smith
exaly   +3 more sources

Post-marketing surveillance

British journal of clinical pharmacology, 1988
When a new drug is released for general therapeutic use, little is known about its potential adverse effects. Premarketing clinical trials include small numbers of patients and thus rare adverse effects may not be detected. Their duration is short, when compared with the potential future routine clinical use of the drug, and thus adverse effects due to
J.-R. Laporte, X. Carné, D. Capellà
openaire   +3 more sources

[Post-marketing surveillance].

Nederlands tijdschrift voor geneeskunde, 1996
Onlangs deed Roos in dit tijdschift een oproep aan de medische professie collectief te weigeren deel te nemen aan post-marketing surveillance (PMS) (). Hieruit blijkt dat er nogal wat verwarring bestaat over de definitie van PMS. Wij zouden de door hem beschreven vorm, waarbij artsen onder het mom van PMS een geldelijke beloning ontvangen voor hun ...
de Koning, G. H. P., Egberts, A C, van Puijenbroek, E P   +2 more
  +8 more sources

Post‐marketing surveillance of buprenorphine

Pharmacoepidemiology and Drug Safety, 2004
AbstractPurposeThis study was undertaken to evaluate the adverse consequences of recently introduced higher strength (0.4 and 2.0 mg per tablet) buprenorphine in Indian market. Buprenorphine, a partial opiate agonist and antagonist, is an emerging alternative to methadone as an agent for long‐term treatment of opiate dependence.MethodsThe current ...
Rajat, Ray, Hemraj, Pal, Rajesh, Kumar, Pallab, Maulick, R, Mangla   +4 more
openaire   +2 more sources

The rationale for a post-marketing surveillance*

Human Reproduction, 1987
Post-marketing surveillance is essential in order to protect patients against avoidable risks from medication. Complete assessment of a drug cannot, for practical reasons, be made before marketing. There are several methods which can be used in post-marketing surveillance.
openaire   +2 more sources

Post-marketing surveillance.

Triangle; the Sandoz journal of medical science, 1981
The term post-marketing surveillance is a term which should be applied to all forms of monitoring marketed drugs for all aspects of their potential to produce adverse reactions.
openaire   +3 more sources